Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease

Sleep Medicine

Volumn 16, Issue 9, 2015, Pages 1123-1130

  Wang, Yeya ^a   Hu, Ke ^a   Liu, Kun ^b   Li, Ze ^b   Yang, Jun ^b   Dong, Yan ^b   Nie, Meiling ^b   Chen, Junwen ^a   Ruan, Yushu ^a   Kang, Jing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Airway inflammation; Chronic obstructive pulmonary disease; Continuous positive airway pressure; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD OXYGEN TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HYPOXEMIA; LUNG LAVAGE; MALE; MIDDLE AGED; NEUTROPHIL COUNT; NOCTURNAL HYPOXEMIA; OVERLAP SYNDROME; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SLEEP DISORDERED BREATHING; SLEEP TIME; AGED; BRONCHOALVEOLAR LAVAGE FLUID; COMPLICATION; METABOLISM; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP APNEA, OBSTRUCTIVE;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939539276     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.04.019     Document Type: Article

References (44)

1. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 2009, 64(7):631-636.
2. Nadeem R., Molnar J., Madbouly E.M., et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013, 9(10):1003-1012.
3. Mannino D.M., Gagnon R.C., Petty T.L., et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160(11):1683-1689.
4. Flenley D.C. Sleep in chronic obstructive lung disease. Clin Chest Med 1985, 6(4):51-61.
5. Sanders M.H., Newman A.B., Haggerty C.L., et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003, 167(1):7-14.
6. Marin J.M., Soriano J.B., Carrizo S.J., et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010, 182(3):325-331.
7. Donaldson G.C., Seemungal T.A., Patel I.S., et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003, 22(6):931-936.
8. Bhowmik A., Seemungal T.A., Sapsford R.J., et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55(2):114-120.
9. Keatings V.M., Collins P.D., Scott D.M., et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153(2):530-534.
10. Di Stefano A., Capelli A., Lusuardi M., et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998, 158(4):1277-1285.
11. Donaldson G.C., Seemungal T.A., Patel I.S., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128(4):1995-2004.
12. Keatings V.M., Barnes P.J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997, 155(2):449-453.
13. Devouassoux G., Lévy P., Rossini E., et al. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. J Allergy Clin Immunol 2007, 119(3):597-603.
14. Aihara K., Oga T., Chihara Y., et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 2013, 17(2):597-604.
15. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Updated December 2009, accessed 16.04.10. http://www.goldcopd.com.
16. Drost E.M., Skwarski K.M., Sauleda J., et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005, 60(4):293-300.
17. Lacedonia D., Salerno F.G., Sabato R., et al. Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome). Respir Med 2011, 105(2):303-309.
18. Carpagnano G.E., Resta O., Ventura M.T., et al. Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma. J Intern Med 2006, 259(3):323-331.
19. Iber C., Ancoli-Israel S., Chesson A., et al. The AASM manual for scoring of sleep and associated events: rules, terminology and technical specifications 2007, for the American Academy of Sleep Medicine, American Academy of Sleep Medicine, Westchester IL. 1st ed.
20. Liebler J.M., Markin C.J. Fiberoptic bronchoscopy for diagnosis and treatment. Crit Care Clin 2000, 16(1):83-100.
21. Weitzenblum E., Chaouat A., Kessler R., et al. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5(2):237-241.
22. Kushida C.A., Chediak A., Berry R.B., et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008, 4(2):157-171. Positive Airway Pressure Titration Task Force, American Academy of Sleep MedicineAmerican Academy of Sleep Medicine.
23. Fortuna A.M., Miralda R., Calaf N., et al. Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome. Respir Med 2011, 105(4):630-636.
24. Nural S., Günay E., Halici B., et al. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 2013, 36(1):66-74.
25. Shiina K., Tomiyama H., Takata Y., et al. Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respir Med 2012, 106(9):1335-1341.
26. Philippe C., Boussadia Y., Prulière-Escabasse V., et al. Airway cell involvement in intermittent hypoxia-induced airway inflammation. Sleep Breath 2015, 19(1):297-306.
27. Takabatake N., Nakamura H., Abe S., et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161(4):1179-1184.
28. Gozal D., Serpero L.D., Kheirandish-Gozal L., et al. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep 2010, 33(3):319-325.
29. Kaushal N., Ramesh V., Gozal D. TNF-α and temporal changes in sleep architecture in mice exposed to sleep fragmentation. PLoS ONE 2012, 7:e45610.
30. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85(3):1151-1158.
31. Minoguchi K., Tazaki T., Yokoe T., et al. Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004, 126(5):1473-1479.
32. Steiropoulos P., Kotsianidis I., Nena E., et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 2009, 32(4):537-543.
33. Xie X., Pan L., Ren D., et al. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 2013, 14(11):1139-1150.
34. Michlewska S., Dransfield I., Megson I.L., et al. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J 2009, 23(3):844-854.
35. Feng X., Deng T., Zhang Y., et al. Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumor necrosis factor α and growth arrest-specific gene 6. Immunology 2011, 132(2):287-295.
36. Borges V.M., Vandivier R.W., McPhillips K.A., et al. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am J Physiol Lung Cell Mol Physiol 2009, 297(4):L586-95.
37. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001, 18(Suppl. 34):50-59.
38. Huber A.R., Kunkel S.L., Todd R.F., et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254(5028):99-102.
39. Diamond M.S., Staunton D.E., de Fougerolles A.R., et al. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990, 111(6 Pt 2):3129-3139.
40. Toraldo D.M., De Nuccio F., Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath 2010, 14(2):115-123.
41. Stanchina M.L., Welicky L.M., Donat W., et al. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med 2013, 9(8):767-772.
42. Machado M.C., Vollmer W.M., Togeiro S.M., et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010, 35(1):132-137.
43. Wang T.Y., Lo Y.L., Lee K.Y., et al. Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea. Respir Res 2013, 14:66.
44. McNicholas W.T. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 2009, 180(8):692-700.